Dr. Reddy’s can now sell a generic version of Suboxone Film. The court victory will bring generic versions of the treatment into the U.S. four years sooner than expected and help reduce the price of a drug that can cost about $500 per month.
Suboxone Film was developed by Indivior, which has hiked the price of the drug four times since 2016. The twice-a-day treatment costs $8.56 a dose.
Dr. Reddy’s version began selling last month at $6.33 per dose. Analysts expect prices to drop as much as 70 percent.
The legal battle between Dr. Reddy’s and Indivior, which began selling the treatment in August 2016, centers on whether Dr. Reddy’s version of Suboxone Film violates a patent.
In June 2018, despite the patent dispute, Dr. Reddy’s launched the product in stores, but had to halt sales about a month later. In February, the U.S. Supreme Court ruled that Dr. Reddy’s could resume sales, saying that Dr. Reddy’s was likely to win its patent case.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
